Marksans Pharma Q2 Results

  • BSE: 524404
  • NSE: MARKSANS
  • ISIN: INE750C01026
  • Sector: Biotechnology & Drugs
BSE
331.65-1.35 (-0.41%)
Volume1.34 M
Updated: Mon 17 Aug, 2026 | 15:57:33
NSE
331.45-1.55 (-0.47%)
Volume13.01 M
Updated: Mon 17 Aug, 2026 | 15:31:07
Today: 325.55
345.70
52-Wk: 156.00
336.80

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Marksans Pharma Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 26QoQ CompSep 24YoY Comp
    Total Operating Expense 602.83652.6311.03%525.7514.66%
    Depreciation/ Amortization 26.9224.8616.51%19.5137.96%
    Operating Income 117.58188.1752.65%116.171.21%
    Net Income 98.25157.1768.48%96.721.59%
    Other Operating Expenses Total 163.52170.002.41%163.69-0.10%
    Net Income Before Taxes 133.33206.5774.07%124.607.01%
    Total Revenue 720.41840.8016.20%641.9212.23%
    Selling/ General/ Admin Expenses Total 103.80114.295.51%84.1623.35%
    Diluted Normalized EPS 2.173.4768.22%2.131.88%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

          ✕

          Wait for it…

          Log in to our website to save your bookmarks. It'll just take a moment.

          ✕

          Wait for it…

          Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.